|  | MRSA (%) | MSSA (%) | Total (%) |
---|---|---|---|---|
 |  | N = 68 | N = 202 | N = 270 |
E-S | E- S, CI-S | 2 (2.9) | 118(58.4%) | 120 (44.5) |
(n = 123) | E- S, CI-R | 3(4.4) | x | 03(1.1) |
E-R (n = 147) | E- R, CI-S (iMLSB) | 19(27.9) | 12 (5.9) | 31(11.5) |
E-R,CI-R (cMLSB) | 37 (54.4) | 42 (20.8) | 79 (29.2) | |
E-R, CI-S (MS Phenotype) | 7 (10.3) | 30 (14.8) | 37(13.7) |